Clinical trial · Interventional
Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy
Randomized Study of Intrathoracic Side-to-side Stapled Esophagogastric Anastomosis Versus Circular-Stapled Technique in Ivor-Lewis Oesophagectomy
NCT01242124CI-TRIAL-00020277unknownPhase 2 / Phase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine the safety and efficacy of the side-to-side stapled intrathoracic esophagogastric anastomosis in Ivor-Lewis Oesophagectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| circular-stapled esophagogastric anastomosis | Procedure | — | UNRESOLVED |
| side-to-side stapled esophagogastric anastomosis | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- side-to-side stapled esophagogastric anastomosis arm
- interventionNames
- Procedure: side-to-side stapled esophagogastric anastomosis
- type
- ACTIVE_COMPARATOR
- label
- circular-stapled esophagogastric anastomosis arm
- interventionNames
- Procedure: circular-stapled esophagogastric anastomosis
Primary outcomes (1)
- measure
- Long and short outcome related with anastomoses
- timeFrame
- 3 year
- description
- Include anastomotic leakage,anastomotic stricture,regurgitation,heartburn, dumping syndrome and anastomoses diameter.
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Cancer of the distal esophagus or gastroesophageal junction confirmed by biopsy (squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma) clinical stage I, II, or III. * Received no previous treatment for esophageal cancer * Adequate bone marrow, liver and kidney function * Patients must be able to understand the nature consent of the study and give written informed consent. Exclusion Criteria: * Age \< 18 years * History of significant heart disease * Inoperable on the basis of co-existent medical problems
References
Publications (0)
Data not yet available
No reference posted for this study.